Core Viewpoint - China Life Insurance (02628.HK) has shown strong technical performance, breaking out of a previous sluggish phase and establishing a mid-term upward trend, with significant trading volume indicating increased investment in the financial insurance sector [1][3]. Technical Analysis - The stock price has surpassed key resistance levels of 16.00 to 16.14 HKD and is approaching a short-term resistance level of 17.10 HKD. A solid hold above this level could pave the way for challenges to previous highs of 19 HKD and even 20.50 HKD [3]. - The technical structure displays a typical W-bottom rebound, supported by ideal trading volume, indicating market consensus on the rebound and suggesting the potential for a new mid-term upward trend [3]. - Technical indicators such as the MACD show a bullish momentum with a golden cross and increasing histogram, while the RSI is above 70, indicating overbought conditions but without clear signs of weakness [3][6]. Market Signals - Currently, the market has set a short-term target price for China Life at 18.42 HKD, suggesting approximately 2.91% upside potential, with mid-term potential to challenge above 20 HKD [6]. - The market sentiment remains highly bullish, with 16 strong buy signals identified, reflecting a strong technical buying consensus [6]. Investment Strategy - Investors are advised to monitor the consolidation platform between 16.10 and 16.30 HKD. If the stock price maintains stability and breaks above 17.20 HKD with increased volume, it will confirm the breakout, allowing for incremental buying with targets set between 19 and 20.50 HKD [9].

Core Viewpoint - China Life Insurance (02628.HK) is experiencing a strong upward trend in its stock price, currently at 17.16 HKD, reflecting a 1.06% increase, following a rebound from a short-term support level of 16.2 HKD [1] Technical Analysis - The stock price has surpassed all major technical moving averages, including the 10-day moving average at 16.4 HKD, the 30-day moving average at 15.63 HKD, and the 60-day moving average at 15.23 HKD, indicating a bullish structure [1] - The stock is approaching the first resistance level at 17.3 HKD, with a potential target of 18.3 HKD if this level is breached [2] - The recent volatility is reflected in a 6.8% fluctuation over five days, with an RSI index at 72, indicating a technical overbought condition [3] - The overall technical indicators are rated as "strong buy," with a signal strength of 16 points, supported by bullish momentum across all categories [3] - The MACD has completed a golden cross and maintains an expanding trend, supporting a continued upward pattern [3] - The price has successfully broken through the Ichimoku cloud, suggesting further upward potential in the coming weeks [3] Derivative Products Performance - On June 6, China Life's related structured products performed well, with a 2.76% increase in the underlying stock, leading to significant gains in derivatives [4] - The Societe Generale bull certificate (53998) led with a 15% increase, outperforming the underlying stock, showcasing the leverage advantage of bull certificates in rising markets [4] Investment Options - Current market conditions provide diverse investment options through China Life's related structured products, with call options offering a leverage of 4.1 times [7] - Bull certificates from HSBC (53706) and JPMorgan (53835) offer over 5 times actual leverage, with a buyback price set at 14 HKD [7] - For bearish strategies, Citigroup's bear certificate (56865) offers a leverage of 4.7 times, with a buyback price set at 20 HKD, providing a favorable risk-reward ratio [7] Summary - China Life is in a healthy upward phase with strong volume-price support and trend indicator resonance, but caution is advised due to potential overbought conditions and divergence risks [10]